Sangamo Therapeutics Inc (NASDAQ:SGMO) price on current trading day, rose 16.97% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.64.
A look at the stock’s price movement, the level at last check in today’s session was $0.55, moving within a range at $0.556 and $0.6474. The beta value (5-Year monthly) was 1.243. Turning to its 52-week performance, $3.18 and $0.41 were the 52-week high and 52-week low respectively. Overall, SGMO moved 24.18% over the past month.
Sangamo Therapeutics Inc’s market cap currently stands at around $156.58 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SGMO is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 1 recommend SGMO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SGMO’s current price about 22.81% and 27.67% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 68.01, while 7-day volatility ratio is 8.05% and 8.63% in the 30-day chart. Further, Sangamo Therapeutics Inc (SGMO) has a beta value of 1.19. Analysts have given the company’s stock an average 52-week price target of $4, forecast between a low of $2 and high of $19. Looking at the price targets, the low is -212.5% off recent price level in today’s trading while to achieve the yearly target high, it has to move -2868.75%. Nonetheless, investors will most likely welcome a -525.0% jump to $4 which is the analysts’ median price.
If we refocus on Sangamo Therapeutics Inc (NASDAQ:SGMO), historical trading data shows that trading volumes averaged 5.66 over the past 10 days and 5.10 million over the past 3 months. The company’s latest data on shares outstanding shows there are 245.40 million shares.
The 3.16% of Sangamo Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 21.97% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 24.18 million on 2025-06-30, giving us a short ratio of 4.1. The data shows that as of 2025-06-30 short interest in Sangamo Therapeutics Inc (SGMO) stood at 995.9999999999999 of shares outstanding, with shares short falling to 31.01 million registered in 2025-05-30. Current price change has pushed the stock 61.49% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SGMO stock continues to rise going into the next quarter.
